Spectral Medical Inc
TSX:EDT
Spectral Medical Inc
TSX:EDT
Price:
0.43 CAD
-3.37%
Market Closed
Updated:
May 5, 2024
Spectral Medical Inc
Cash from Financing Activities
|
Spectral Medical Inc
Cash from Financing Activities Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
AUPH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Financing Activities
$81.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Financing Activities
$14.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Financing Activities
$842k
|
CAGR 3-Years
-85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Financing Activities
$142m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Financing Activities
-$5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Spectral Medical Inc's Cash from Financing Activities?
Cash from Financing Activities
5.4m
CAD
5.4m
CAD
Based on the financial report for Dec 31, 2023, Spectral Medical Inc's Cash from Financing Activities amounts to 5.4m CAD.
What is Spectral Medical Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-1%
-1%
Over the last year, the Cash from Financing Activities growth was -43%. The average annual Cash from Financing Activities growth rates for Spectral Medical Inc have been 2% over the past three years , 1% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
